RESUMO
Changes in the expression of nuclear ß-catenin are responsible for tumorigenesis. Beta-catenin acts synergistically with the TGF-ß/BMPs pathway. This interaction leads to greater dentin deposition and may explain the differences between distinct tooth morphologies and hamartomas. The aim of this study was to investigate the role of ß-catenin, BMP4 and TGF-ß in the development of odontomas. This cross-sectional, retrospective, immunohistochemical study evaluated 30 compound odontomas, 30 complex odontomas and 17 tooth germs. The results showed that BMP4 and TGF-ß were more immunoexpressed in the ectomesenchyme of complex odontomas (median = 33.7, p < 0.001; median = 76.4, p = 0.002, respectively). Higher immunoexpression of BMP4 and TGF-ß was also observed in the epithelium of tooth germs (median = 2.0, p < 0.001; median = 120.3, p < 0.001, respectively). TGF-ß and BMP4 showed a positive and significant correlation (p < 0.001). Both TGF-ß and BMP4 were positively correlated with nuclear ß-catenin in ectomesenchyme (p = 0.047 and p = 0.023, respectively). Developing teeth exhibited higher concentrations of the proteins studied in odontogenic epithelium, especially during the bud and cap stages. Higher immunoexpression in odontomas occurred mainly in the ectomesenchyme. We therefore suggest that changes in the ectomesenchyme can lead to the development of odontomas.
Assuntos
Odontoma , Animais , Odontoma/veterinária , beta Catenina/metabolismo , Fator de Crescimento Transformador beta , Estudos Retrospectivos , Estudos TransversaisRESUMO
BACKGROUND: Primordial odontogenic tumour is a benign mixed neoplasm of recent description, which has histological similarities with other odontogenic tumours such as the ameloblastic fibroma. In this article, we investigate the architecture of the sub-epithelial layer of mesenchymal cells expressing the marker CD34 in primordial odontogenic tumour. OBJECTIVE: Analyse the spatial patterns of CD34 expression in primordial odontogenic tumour and compare them with those in ameloblastic fibroma and the normal tooth germ by means of objective imaging approaches, to better characterise these lesions. METHODS: Two cases of primordial odontogenic tumour, four cases of ameloblastic fibroma and two cases of tooth germ in cap and bell stages were used for morphological, structural and immunohistochemical analyses. RESULTS: CD34 expression was found in vascular endothelium of primordial odontogenic tumour, ameloblastic fibroma and tooth germ. In addition, a characteristic sub-epithelial expression was observed only in primordial odontogenic tumour, corresponding to 84%-86% of the sample boundaries. Moreover, the zone expressing CD34 corresponded with a higher cellularity, which was absent in ameloblastic fibroma and tooth germ. CONCLUSION: Image analysis of the primordial odontogenic tumour architecture revealed characteristics absent in other odontogenic tumours and tooth germs. This study provides additional information to support the idea that this neoplasm is a distinct entity from early stage AF or developing odontoma.
Assuntos
Fibroma , Tumores Odontogênicos , Odontoma , Humanos , Tumores Odontogênicos/patologia , Germe de Dente , Odontoma/patologia , Moléculas de Adesão Celular/análiseRESUMO
BACKGROUND: Hybrid odontogenic lesions combine histopathological characteristics of two or more odontogenic cysts and/or tumours. The aim of this study was to evaluate the available data on hybrid odontogenic lesions (HOL) and to analyse their epidemiological/clinical features and biological behaviour. METHODS: An electronic search was done in January 2021 using multiple databases. Eligibility criteria encompassed publications with sufficient clinical and histological information to confirm the tumours' diagnoses. RESULTS: A total of 147 articles were included in this study, comprising 203 cases. Calcifying odontogenic cyst associated with odontoma (COC/OD) (37/18.2%) was the most common HOL. Females were more affected with a mean age of 24.9 years. Lesions presented as asymptomatic swellings, with a mean evolution time of 8.2 months (0.3-96), and mean tumour size of 4.8 cm (0.3-7). Radiographic aspects frequently showed radiolucent (139/68.4%) and unilocular (52/25.6%) images with well-defined limits (48/23.6%). The lesions mostly affected mandibular pre-molars (69/34%) and mandibular molars (69/34%) regions. Enucleation (89/43.8%) and surgical excision (59/29%) were the most common treatment modalities. The mean follow-up time was 33.8 months (0.5-216 months) and recurrences were observed in four cases (1.9%), all of which were central odontogenic fibroma associated with central giant cell granuloma (COF/CGCG). CONCLUSION: COC/OD is the most common HOL and recurrence is a rare event, being usually associated with the diagnosis of COF/CGCG.
Assuntos
Granuloma de Células Gigantes , Cisto Odontogênico Calcificante , Cistos Odontogênicos , Tumores Odontogênicos , Odontoma , Adulto , Feminino , Humanos , Cistos Odontogênicos/diagnóstico por imagem , Cistos Odontogênicos/epidemiologia , Tumores Odontogênicos/diagnóstico por imagem , Tumores Odontogênicos/epidemiologia , Odontoma/diagnóstico por imagem , Odontoma/epidemiologia , Adulto JovemRESUMO
BACKGROUND: BRAF p.V600E is reported in up to 80% of ameloblastomas. Despite the high frequency, the presence of this mutation in different histopathological areas of the tumour has not been investigated. This information has an important role in the use of BRAF p.V600E assessment as an auxiliary tool in the differential diagnosis between unicystic ameloblastoma and other odontogenic cystic lesions, especially when only incisional biopsies are available. Therefore, the purpose of the present study was to investigate BRAF p.V600E heterogeneity in unicystic ameloblastoma. METHODS: Five cases of ameloblastoma and two dentigerous cysts were analysed. The regions exhibiting different microscopic characteristics were selected from each ameloblastoma case and manually dissected. TaqMan allele-specific qPCR or Sanger sequencing was performed to determine BRAF p.V600E status. RESULTS: We screened the mutation in a small cohort of UA and no molecular heterogeneity was found. Four cases of ameloblastoma (80%) exhibited BRAF p.V600E in all different areas evaluated. One case did not harbour the mutation in any microscopic region analysed. The BRAF mutation was absent in the dentigerous cysts. CONCLUSION: Ameloblastomas appear to exhibit a homogeneous profile regarding the BRAF p.V600E no matter what histological feature is observed under light microscopy, suggesting that this molecular test may contribute to establish the correct diagnosis in cases microscopically resembling other odontogenic lesions.
Assuntos
Ameloblastoma , Cistos Odontogênicos , Ameloblastoma/diagnóstico , Ameloblastoma/genética , Diagnóstico Diferencial , Humanos , Mutação , Proteínas Proto-Oncogênicas B-raf/genéticaRESUMO
Ameloblastoma is locally aggressive neoplasm of odontogenic origin comprising about 1% among tumours and cysts that usually occurs in the vicinity of the mandibular molars or ramus of the mandible. Predominantly occurring in third to fifth decade, with no gender propensity. Inadequate treatment may lead to recurrence in certain cases. Even though benign in growth, they are locally aggressive and can occasionally metastasize. Of them, a unique exophytic presentation of plexiform ameloblastoma in a 22-year-old male patient is documented as follows.
RESUMO
OBJECTIVE: Driver oncogenic mutations have been reported in several benign neoplasms. While ameloblastomas show BRAF p.V600E mutations, adenomatoid odontogenic tumours harbour either KRAS p.G12R or p.G12 V. The lack of understanding of the core molecular changes involved in tumour initiation and progression represents a critical barrier to developing new strategies for cancer detection and prevention. Considering the fact that ameloblastoma and adenomatoid odontogenic tumours can originate from dental follicles, we hypothesized that the BRAF and KRAS mutations might be early events in odontogenic tumours tumourigenesis. We aimed to assess BRAF and KRAS mutations in dental follicles associated with asymptomatic impacted teeth. DESIGN: Forty-eight dental follicles containing odontogenic epithelial remnants were included in the study. As ameloblastomas most often occur in the posterior mandible and adenomatoid odontogenic tumours have a predilection for the anterior jaws, we assessed by allele-specific qPCR the presence of BRAF p.V600E in 32 dental follicles associated with impacted 3rd mandibular molar teeth and KRAS p.G12 V and KRAS p.G12R mutations in 16 dental follicle specimens obtained from around impacted anterior teeth. Sanger sequencing was used as an additional method. RESULTS: None of the dental follicle cases tested positive for the mutations. CONCLUSION: In conclusion, we tried to detect the early genetic events associated with odontogenic tumours development in dental follicles, but we were unable to showcase that BRAF p.V600E and KRAS p.G12R or p.G12 V mutations are the early genetic events associated with odontogenic tumours development.
Assuntos
Adenoma/genética , Saco Dentário/patologia , Mutação , Tumores Odontogênicos/genética , Carcinogênese , Humanos , Proteínas Proto-Oncogênicas B-raf/genética , Proteínas Proto-Oncogênicas p21(ras)/genéticaRESUMO
OBJECTIVE: To evaluate the immunoexpression of DNA base excision repair (BER) [apurinic/apyrimidinic endonuclease 1 (APE-1), X-ray repair cross complementing 1 (XRCC-1)] and nucleotide excision repair (NER) [xeroderma pigmentosum complementation group (XPF)] proteins in benign epithelial odontogenic lesions with different biological behaviors. DESIGN: Thirty solid ameloblastomas, 30 non-syndromic odontogenic keratocysts (NSOKCs), 29 syndromic odontogenic keratocysts (SKOCs), 30 dentigerous cysts (DCs) and 20 dental follicles (DFs) were evaluated quantitatively for APE-1, XRCC-1 and XPF through immunohistochemistry. RESULTS: Nuclear expression of APE-1 was significantly higher in NSOKCs, SOKCs, and ameloblastomas in comparison to DCs (p < 0.001). Nuclear expression of XRCC-1 was higher in NSOKCs and SOKCs than in DCs (p < 0.05). At the nuclear level, XPF expression was higher in NSOKCs and SOKCs than in DCs and ameloblastomas (p < 0.05). A statistically significant higher expression of APE-1 (nuclear), XRCC-1 (nuclear), and XPF (nuclear and cytoplasmic) was found in all odontogenic lesion samples as compared to DFs (p < 0.05). For all lesions, there was a positive correlation between nuclear expression of APE-1 and XRCC-1 or XPF (p < 0.05). CONCLUSIONS: Our results suggest a potential involvement of APE-1, XRCC-1 and XPF proteins in the pathogenesis of benign epithelial odontogenic lesions, especially in those with more aggressive biological behavior, such as ameloblastomas, NSOKCs, and SOKCs. We also showed that the expression of APE-1 was positively correlated with the nuclear expression of XRCC-1 and XPF, which may suggest an interaction between the BER and NER pathways in all odontogenic lesions studied herein.
Assuntos
Ameloblastoma , Reparo do DNA , DNA Liase (Sítios Apurínicos ou Apirimidínicos) , Proteínas de Ligação a DNA , Cisto Dentígero , Cistos Odontogênicos , Proteína 1 Complementadora Cruzada de Reparo de Raio-X , Ameloblastoma/genética , DNA , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/metabolismo , Proteínas de Ligação a DNA/metabolismo , Cisto Dentígero/genética , Expressão Gênica , Humanos , Cistos Odontogênicos/genética , Proteína 1 Complementadora Cruzada de Reparo de Raio-X/metabolismoRESUMO
BRAF p.V600E é a mutação mais comum em ameloblastomas convencionais e ameloblastomas unicísticos. Sabe-se que os cistos odontogênicos não apresentam esta mutação e representam um dos principais diagnósticos diferenciais dos ameloblastomas, em especial de sua variante unicística. Muitos casos de ameloblastoma unicístico e de alguns cistos odontogênicos, como o cisto dentígero e o cisto inflamatório radicular, compartilham semelhanças clínicas e radiográficas, podendo exibir características histológicas semelhantes em biópsias incisionais ou em tecidos muito inflamados, dificultando o diagnóstico preciso da lesão. As diferentes áreas morfológicas encontradas em um ameloblastoma e as características moleculares de cada uma destas regiões devem ser investigadas com o objetivo de determinar se a avaliação molecular ajudaria a estabelecer o diagnóstico correto de ameloblastoma independente de sua apresentação microscópica, contribuindo para a escolha do tratamento mais apropriado pelo cirurgião bucomaxilofacial. Portanto, o objetivo deste estudo foi verificar o status de mutação do gene BRAF em regiões histológicas de ameloblastomas que exibiam aspectos microscópicos distintos. Foram analisados cinco casos de ameloblastomas, sendo três casos classificados como Ameloblastoma unicístico e dois casos classificados como Ameloblastoma (convencionais), porém com grandes áreas de degeneração cística. Duas ou três regiões exibindo diferentes características microscópicas foram selecionadas de cada caso e enriquecidas por meio de microdissecção manual. Reações de qPCR ou de sequenciamento de Sanger foram realizadas para determinar a presença da mutação BRAF p.V600E. Observamos que quatro casos exibiram a mutação BRAF p.V600E em todas as diferentes áreas microscópicas avaliadas, enquanto que o único caso negativo para mutação em BRAF também demonstrou negatividade em todas as regiões microscópicas avaliadas. Nossos resultados sugerem que o ameloblastoma exibe um perfil homogêneo em relação à presença da mutação BRAF p.V600E ao longo de regiões histológicas com diferentes características microscópicas.
BRAF p.V600E is the most common mutation in conventional ameloblastomas and unicystic ameloblastomas. It is known that odontogenic cysts do not present this mutation and that they represent an important differential diagnosis for ameloblastomas, especially its unicystic variant. Several unicystic ameloblastoma and some odontogenic cysts, such as dentigerous and radicular cysts, share clinical and radiographic features, and may exhibit similar histological characteristics in incisional biopsies or in severely inflamed tissues, making it difficult to accurately diagnose the lesion. Different morphological areas found in ameloblastomas and the molecular characteristics of each of these regions should be investigated in order to determine whether molecular evaluation would help to establish the correct diagnosis, contributing to select the most appropriate treatment by oral surgeons. Therefore, the aim of this study was to verify BRAF mutational status in histological areas of ameloblastomas presenting different microscopic features. Five cases of ameloblastoma were analysed, with three cases classified as unicystic ameloblastoma and two cases classified as (conventional) ameloblastoma with large areas of cystic degeneration. Two or three regions exhibiting different microscopic characteristics were selected from each case and enriched by manual microdissection. qPCR or Sanger sequencing were performed to determine BRAF p.V600E status. We observed that four cases exhibited BRAF p.V600E in all different areas evaluated, while the only negative case for BRAF mutation also demonstrated negativity in all microscopic regions analyzed. Our results suggest that ameloblastomas appear to exhibit a homogeneous profile regarding BRAF p.V600E along histological regions of the tumor presenting different microscopic appearance.
Assuntos
Ameloblastoma , Cistos Odontogênicos , Tumores Odontogênicos , Mutação , Cisto Dentígero , Cisto Radicular , NeoplasiasRESUMO
OBJECTIVES: To analyse the occurrence of calcifying epithelial odontogenic tumours (CEOT) based on biopsy records from different Brazilian geographic regions and to contrast the data with a review of the literature. MATERIALS AND METHODS: A 2-step study was conducted. Step 1 consisted of a collaborative study of biopsies obtained from 1953 to 2017 at six Brazilian oral and maxillofacial pathology centres. Evaluation of 86,268 biopsy records was performed. Demographic and histopathological diagnosis data were assessed. In Step 2, a review of the literature of case reports and cases series of CEOT identified across five electronic databases was conducted. RESULTS: In the collaborative study, 32 cases of CEOT were evaluated. This figure represented 0.03% of the oral and maxillofacial lesions and 1.7% of all odontogenic tumours across the centres. Women in the fourth decade of life were more affected. CEOT occurred more in the mandible than in the maxilla (ratio 1.9:1). The review of the literature showed that Asian individuals were more affected by this neoplasm. CONCLUSIONS: Useful knowledge on the epidemiology, treatment and follow-up of CEOT has been provided. Demographic data and clinical features of the cases presented in this collaborative study were quite similar to those of studies reported worldwide.
Assuntos
Tumores Odontogênicos/diagnóstico , Neoplasias Cutâneas/diagnóstico , Brasil , Feminino , Humanos , Masculino , Mandíbula/patologia , Maxila/patologiaRESUMO
BACKGROUND: Cemento-ossifying fibroma (COF) is a benign fibro-osseous neoplasm of uncertain pathogenesis, and its treatment results in morbidity. MicroRNAs (miRNA) are small non-coding RNAs that regulate gene expression and may represent therapeutic targets. The purpose of the study was to generate a comprehensive miRNA profile of COF compared to normal bone. Additionally, the most relevant pathways and target genes of differentially expressed miRNA were investigated by in silico analysis. METHODS: Nine COF and ten normal bone samples were included in the study. miRNA profiling was carried out by using TaqMan® OpenArray® Human microRNA panel containing 754 validated human miRNAs. We identified the most relevant miRNAs target genes through the leader gene approach, using STRING and Cytoscape software. Pathways enrichment analysis was performed using DIANA-miRPath. RESULTS: Eleven miRNAs were downregulated (hsa-miR-95-3p, hsa-miR-141-3p, hsa-miR-205-5p, hsa-miR-223-3p, hsa-miR-31-5p, hsa-miR-944, hsa-miR-200b-3p, hsa-miR-135b-5p, hsa-miR-31-3p, hsa-miR-223-5p and hsa-miR-200c-3p), and five were upregulated (hsa-miR-181a-5p, hsa-miR-181c-5p, hsa-miR-149-5p, hsa-miR-138-5p and hsa-miR-199a-3p) in COF compared to normal bone. Eighteen common target genes were predicted, and the leader genes approach identified the following genes involved in human COF: EZH2, XIAP, MET and TGFBR1. According to the biology of bone and COF, the most relevant KEGG pathways revealed by enrichment analysis were proteoglycans in cancer, miRNAs in cancer, pathways in cancer, p53-, PI3K-Akt-, FoxO- and TGF-beta signalling pathways, which were previously found to be differentially regulated in bone neoplasms, odontogenic tumours and osteogenesis. CONCLUSION: miRNA dysregulation occurs in COF, and EZH2, XIAP, MET and TGFBR1 are potential targets for functional analysis validation.
Assuntos
Neoplasias Ósseas/genética , Neoplasias Ósseas/metabolismo , Fibroma Ossificante/genética , Fibroma Ossificante/metabolismo , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Redes Reguladoras de Genes , MicroRNAs/genética , Adolescente , Adulto , Biologia Computacional , Regulação para Baixo , Proteína Potenciadora do Homólogo 2 de Zeste/genética , Feminino , Fatores de Transcrição Forkhead/metabolismo , Estudos de Associação Genética , Humanos , Masculino , MicroRNAs/classificação , Pessoa de Meia-Idade , Proteínas de Neoplasias/metabolismo , Tumores Odontogênicos , Osteogênese , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Serina-Treonina Quinases/genética , Proteínas Proto-Oncogênicas c-met/genética , RNA não Traduzido , Receptor do Fator de Crescimento Transformador beta Tipo I , Receptores de Fatores de Crescimento Transformadores beta/genética , Proteína Supressora de Tumor p53/metabolismo , Regulação para Cima , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X/genética , Adulto JovemRESUMO
O cementoblastoma benigno é uma lesão patológica rara, de origem odontogênica, caracterizada pela proliferação anormal de cementoblastos, o que forma, consequentemente, uma massa de tecido semelhante a cemento. Na maioria dos casos, é encontrado em associação com primeiros molares inferiores. Ocorre mais frequentemente em caucasianos, entre as 2ª e 3ª décadas de vida, afetando, assim, raramente dentes decíduos. Geralmente, apresenta sintomatologia dolorosa e expansão de corticais ósseas. Seu tratamento vai desde a remoção completa da lesão com extração do dente envolvido até o tratamento endodôntico com preservação do elemento dentário. No presente artigo, relata-se um caso de cementoblastoma benigno em uma paciente de 23 anos sem sintomatologia dolorosa e ao exame clínico nada de anormal foi observado, sendo tratada através da remoção da lesão e extração do dente... (AU)
The benign cementoblastoma is a rare pathologic wound, of odontogenic origin feature of the abnormal cementoblast proliferation, resulting hence a coat mass like to cement. Usually is found in association with the first bottom molars. This happen more frequently on Caucasian, between the 2ª and 3ª decade of life, affecting rarely the primary dentition . Generally show a painful symptomatic and expansion of the cortical bone. The treatment starts with the removal wound full of with the tooth extraction involved in the endodontico treatment , with preservations of the dental element. This article descrambles a cementobastoma benign case in a patient with 23 years old, asymptomatic and the clinic exam nothing abnormal was found. Was treated through the wound removal and the tooth extraction... (AU)
Assuntos
Humanos , Feminino , Adulto Jovem , Neoplasias Bucais/cirurgia , Cementoma/cirurgia , Neoplasias Bucais/diagnóstico por imagem , Cementoma/diagnóstico por imagemRESUMO
BACKGROUND: Ameloblastoma (AM) is a benign odontogenic neoplasm characterized by local invasiveness and recurrence. We compared the immunohistochemical expression of matrix metalloproteinases in different clinical types of AM as well as in normal odontogenic tissue. METHODS: Thirteen cases of solid AMs, five cases of unicystic AM and eight pericoronal follicles (PF) were selected and subjected to immunohistochemical investigation for matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions. RESULTS: The expressions of MMP-1 and MMP-2 were very high in the cytoplasm of cells throughout the entire epithelium and in fibroblasts from the adjacent connective tissue. MMP-9 expression was observed in the same location although with weaker staining. The Kruskal-Wallis test showed statistically significant differences in the epithelial expressions of MMP-1 and MMP-2; there was lower expression among solid AMs when compared with unicystic AM and PF. Compared to both types of AM, higher stromal expression of MMP-9 was found in PF. CONCLUSION: MMP-1, MMP-2 and MMP-9 seem to be associated with AM tumour behaviour as well as physiological tissue remodelling within PF.
Assuntos
Ameloblastoma/enzimologia , Saco Dentário/enzimologia , Neoplasias Maxilomandibulares/enzimologia , Metaloproteinases da Matriz/biossíntese , Tumores Odontogênicos/enzimologia , Ameloblastoma/metabolismo , Ameloblastoma/patologia , Tecido Conjuntivo/enzimologia , Tecido Conjuntivo/patologia , Saco Dentário/metabolismo , Saco Dentário/patologia , Epitélio/enzimologia , Epitélio/metabolismo , Epitélio/patologia , Fibroblastos/enzimologia , Fibroblastos/metabolismo , Fibroblastos/patologia , Humanos , Imuno-Histoquímica , Neoplasias Maxilomandibulares/metabolismo , Neoplasias Maxilomandibulares/patologia , Metaloproteinase 1 da Matriz/biossíntese , Metaloproteinase 2 da Matriz/biossíntese , Metaloproteinase 9 da Matriz/biossíntese , Recidiva Local de Neoplasia/enzimologia , Recidiva Local de Neoplasia/metabolismo , Recidiva Local de Neoplasia/patologia , Tumores Odontogênicos/metabolismo , Tumores Odontogênicos/patologiaRESUMO
O tumor odontogênico adenomatoide (TOA) foi considerado como uma entidade clínica distinta, em 1969, por Philipsen e Birn. Trata-se de um tumor odontogênico, de caráter totalmente benigno, assintomático, de crescimento lento e raramente atingindo tamanho maior que 3 cm. Acomete, preferencialmente, a região anterior dos ossos gnáticos, principalmente a maxila, ocorrendo duas vezes mais no gênero feminino, sendo incomum em pacientes maiores que 20 anos. O objetivo deste trabalho é relatar um caso clínico atípico de tumor odontogênico adenomatoide em região anterior de mandíbula, mimetizando cisto radicular, acometendo um paciente de 45 anos, do gênero masculino, tratado com enucleação cirúrgica. O paciente encontra-se atualmente em proservação, não apresentando sinais clínicos e imaginológicos de recidiva. No presente artigo, os aspectos clínicos, radiográficos e histológicos do tumor odontogênico adenomatoide serão discutidos assim como o tratamento recomendado... (AU)
Adenomatoid Odontogenic Tumor (AOT) was so classified as a new tumor in 1969 by Philipsen and Birn. This odontogenic tumor is benign, asymptomatic, has a slow growing and rarely reach a size greater than 3 cm. AOT usually occurs in anterior jaw bones, affects females twice more than males and is unusual in patients older than 20 years-old. The aim of this study is to report an atipic case of AOT in the anterior mandible mimetizing a radicular cyst, affecting a 45 years-old male patient, who was treated by surgical enucleation. The patient has been followed-up and has no clinical and imaging signs of recurrence. In this paper, adenomatoid odontogenic tumor's clinical, radiographic and histological aspects will be discussed, as well the recommended treatment... (AU)
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais , Tumores Odontogênicos , Odontoma , Tumor Adenomatoide/cirurgia , Mandíbula/cirurgia , Cisto Radicular , Arcada Osseodentária/patologiaRESUMO
BACKGROUND: Calcifying cyst odontogenic tumour (CCOT) is a rare benign cystic neoplasm of odontogenic origin. MMPs are responsible for extracellular matrix remodelling and, together their inhibitors and inducer, determinate the level of its turnover in pathological processes, leading to an auspicious microenvironment for tumour development. Thus, our goal was to evaluate matrix metalloproteinases (MMPs-2, -7, -9 and -14), their inhibitors (TIMPs-2, -3, -4 and RECK) and its inductor (EMMPRIN) expression in CCOT. MATERIALS AND METHODS: We used 18 cases of CCOT submitted to immunolocalization of the target proteins and analysed in both neoplastic odontogenic epithelial and stromal compartments. RESULTS: All molecules evaluated were expressed in both compartments in CCOT. In epithelial layer, immunostaining for MMPs, TIMPs, RECK and EMMPRIN was found in basal, suprabasal spindle and stellate cells surrounding ghost cells and ghost cells themselves, except for MMP-9 and TIMP-2 which were only expressed by ghost cells. In stromal compartment, extracellular matrix, mesenchymal (MC) and endothelial cells (EC) were positive for MMP-2, -7, TIMP-3 and -4, while MMP-9, TIMP-2 and RECK were positive only in MC and MMP-14 only in EC. Statistical significance difference was found between both compartments for MMP-9 (P < 0.001), RECK (P = 0.004) and EMMPRIN (P < 0.001), being more expressed in epithelium than in stroma. Positive correlation between both stromal EMMPRIN and RECK expression was found (R = 0.661, P = 0.003). CONCLUSIONS: We concluded that these proteins/enzymes are differentially expressed in both epithelium and stroma of CCOT, suggesting an imbalance between MMPs and their inducer/inhibitors may contribute on the tumour behaviour.
Assuntos
Basigina/análise , Proteínas Ligadas por GPI/análise , Metaloproteinases da Matriz/análise , Tumores Odontogênicos/química , Inibidores Teciduais de Metaloproteinases/análise , Adolescente , Adulto , Células Endoteliais/química , Células Endoteliais/enzimologia , Epitélio/química , Epitélio/enzimologia , Matriz Extracelular/química , Matriz Extracelular/enzimologia , Feminino , Humanos , Masculino , Metaloproteinase 14 da Matriz/análise , Metaloproteinase 2 da Matriz/análise , Metaloproteinase 7 da Matriz/análise , Metaloproteinase 9 da Matriz/análise , Mesoderma/química , Mesoderma/enzimologia , Pessoa de Meia-Idade , Proteínas de Neoplasias/análise , Tumores Odontogênicos/enzimologia , Inibidor Tecidual de Metaloproteinase-2/análise , Inibidor Tecidual de Metaloproteinase-3/análise , Microambiente Tumoral , Adulto Jovem , Inibidor Tecidual 4 de MetaloproteinaseRESUMO
AIM: To document a case of a keratocystic odontogenic tumour (KOT) involving the apical region in the maxilla mimicking a periapical lesion of endodontic origin. SUMMARY: Benign and malignant tumours, including odontogenic lesions, can be erroneously diagnosed as periapical radiolucencies. KOTs mimicking periapical lesions of endodontic origin are uncommon, especially when the lesions involve the maxilla. This article describes a 55-year-old man with a well-delimited, oval-shaped, radiolucent lesion, occupying the middle and apical third of teeth 22 and 23. After 30 days, the clinical and radiographic findings remained unchanged and the patient was referred for surgical removal of the lesion. Clinical, radiographic and histopathological features are also discussed and compared with current literature.
Assuntos
Tumores Odontogênicos/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Tumores Odontogênicos/patologiaRESUMO
O cementoblastoma benigno (CB) é um tumor odontogênico raro, de crescimento lento e ilimitado. Ocorre mais frequentemente em caucasianos, entre as 2ª e 3ª décadas de vida, sem predileção por gênero. Mais comum na mandíbula, área de molares e pré-molares, geralmente envolve o primeiro molar permanente. Em imagem radiográfica, apresenta massa radiopaca delimitada por delgada linha radioluscente, simulando uma hipercementose. Em cortes histológicos, assemelha-se fortemente com osteoma osteoide, osteosarcoma ou osteoblastoma benigno. O objetivo do presente trabalho foi descrever um caso incomum de cementoblastoma. I.D.S., gênero masculino, melanoderma, 32 anos que compareceu ao ambulatório do Grupo de Apoio Aprendizes do Amor Cristão - GAAAC, Brasília - DF, sem queixa de dor, portando lesão na região do 2º molar mandibular esquerdo, apresentando imagem radiográfica sugestiva de cementoblastoma. O tratamento consistiu na remoção completa da lesão acompanhada de extração do dente 37. Após dois anos, observou-se a remissão dos sinais, não havendo recorrência do tumor. O caso relatado apresentou como variante incomum ter acometido indivíduo da raça negra, relacionado ao 2º molar mandibular esquerdo - 3%. O sítio de localização atípico e as discrepâncias encontradas entre o presente relato e a literatura reforçam a importância do diagnóstico e a pesquisa por novas evidências relacionadas ao cementoblastoma.
The cementoblastoma benign (CB) is a rare odontogenic tumor, slow growth and unlimited. It occurs more frequently in caucasians, between 2nd and 3rd decades of life, with no predilection for gender. More common in the mandible area of molars and premolars, usually involving the first permanent molar. In radiographic image shows a radiopaque mass bounded by thin radiolucent line simulating a hypercementosis. Using histological resembles strongly with osteoid osteoma, osteosarcoma and benign osteoblastoma. The aim of this study was to describe an unusual case of cementoblastoma. IDS, male, melanoderma, 32 years old, came to the Grupo de Apoio Aprendizes do Amor Cristão - GAAAC, Brasília - DF, without pain, with a lesion in the 2nd left molar region, presenting radiographic image suggestive of cementoblastoma. The treatment consisted of complete removal of the lesion accompanied by the extraction of the tooth 37. After two years, there was remission of signs, with no tumor recurrence. This case presents unusual variant as the fact that it involved an individual of black, related to 2nd left mandibular molar - 3%. The rarity of the condition and the discrepancies found between this case and the literature of reinforce even more the importance of any new evidence related to cementoblastoma.
Assuntos
Imuno-Histoquímica , Glicoproteínas de Membrana/metabolismo , Neoplasias Maxilomandibulares/metabolismo , Neoplasias Maxilomandibulares/patologia , Cistos Odontogênicos/metabolismo , Cistos Odontogênicos/patologia , Tumores Odontogênicos/patologia , Bancos de Espécimes Biológicos , Antígeno Ki-67 , Proliferação de Células , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Mesoderma/metabolismo , Mesoderma/patologiaRESUMO
INTRODUÇÃO E OBJETIVO: O conhecimento do comportamento biológico de lesões de natureza odontogênica é essencial para tornar a abordagem terapêutica adequada e estabelecer um prognóstico. A produção de metaloproteinases da matriz extracelular (MMPs), a angiogênese e a proliferação celular fornecem subsídios para o crescimento tumoral. O presente artigo tem como objetivo fazer uma revisão de literatura de pesquisas em tumores odontogênicos (TOs) selecionados a partir da nova classificação da Organização Mundial da Saúde (OMS) de 2005 sobre a expressão de MMPs, marcadores angiogênicos e proliferação celular e verificar, nestes estudos, a relação desses marcadores quanto ao comportamento biológico dessas lesões. RESULTADOS: Nota-se que as MMPs -1, -2, -7, -9 e -26 encontram-se mais expressas no componente epitelial e estroma e, particularmente, a -13 em estroma. Uma maior angiogênese é observada em TOs mais agressivos. CD 105 foi mais expresso no TO ceratocístico (TOC) e CD34 em ameloblastomas sólidos (ASs). Relata-se elevada expressão do Ki-67 e p53 no TOC e no AS e baixo índice de proliferação celular no TO adenomatoide (TOA). CONCLUSÃO: Esses resultados mostram que as MMPs participam no processo de invasão e recorrência de algumas lesões odontogênicas, estando associadas ao comportamento biológico desses tumores. A angiogênese é fundamental para fornecer suporte à proliferação celular e esses dois eventos em conjunto estão correlacionados com diferentes níveis de comportamento biológico nos TOs, quando comparados com cistos de natureza odontogênica, o que pode sugerir o uso de inibidores angiogênicos como provável abordagem terapêutica nessas lesões.
INTRODUCTION AND OBJECTIVE: The study of biological behavior of odontogenic lesions is essential to the establishment of appropriate therapeutic approach and prognosis. The production of extracellular matrix metalloproteinases (MMPs), angiogenesis and cell proliferation contribute to tumor growth. This paper aims to review the literature on odontogenic tumors (OT) selected according to the new World Health Organization classification (WHO- 2005) by evaluating the expression of MMPs, angiogenic and cell proliferation. Furthermore, it aims to verify the relation between these markers and the biological behavior of these lesions. RESULTS: it was found that MMPs -1, -2, -7, -9 and -26 had a higher expression in both epithelial component and stroma, and 13 particularly in the stroma. Increased angiogenesis was observed in more aggressive OT. CD105 expression was higher in keratocystic odontogenic tumour (KOT) and CD34 in solid ameloblastomas (SA). It was observed a higher expression of Ki-67 and p53 in SA and KOT and a low cell proliferation rate in the adenomatoid odontogenic tumour (AOT). CONCLUSION: These results show that MMPs are involved in invasion and recurrence of some odontogenic lesions and are associated with the biological behavior of these tumors. Angiogenesis is critical to provide support to cell proliferation and these concomitant events are correlated with different levels of biological behavior in OT when compared to odontogenic cysts, hence the use of angiogenic inhibitors may be a potential therapeutic approach in these lesions.
Assuntos
Matriz Extracelular , Metaloproteinases da Matriz Associadas à Membrana/genética , Proliferação de Células , Tumores Odontogênicos/genéticaRESUMO
O cisto odontogênico ortoqueratinizado (COO) e o tumor odontogênico queratocístico (TOQ) são lesões distintas, com comportamento clínico e características radiográficas semelhantes. Enquanto o COO é classificado como cisto odontogênico, o TOQ, com base na última classificação da OMS em 2005, passou a ser classificado como neoplasia odontogênica. Essa alteração realizada na classificação do TOQ baseou-se em evidências científicas que constataram uma taxa de proliferação celular dessas lesões não compatível com as lesões císticas, fato esse comprovado mediante os dos elevados índices de recidiva encontrados no TOQ. Em função das semelhanças clínicas e radiográficas, a diferenciação histológica dessas lesões torna-se preponderante para o delineamento de um plano de tratamento conservador ou agressivo. Neste trabalho, relata-se um caso de paciente com 28 anos, gênero masculino, leucoderma, com aumento de volume assintomático em mandíbula, na região dos dentes 33, 34 e 35, todos com vitalidade. Os exames de imagem revelaram lesão radiolúcida em parasínfise e corpo mandibular esquerdo. O paciente foi submetido à punção aspirativa, com resultado negativo, e à biópsia incisional. O material coletado foi enviado a um laboratório de anatomopatologia cujo laudo revelou tumor odontogênico queratocístico. Assim sendo, o paciente foi submetido à cirurgia de enucleação com curetagem marginal, evoluindo sem intercorrências no pós-operatório. O material coletado durante a enucleação foi encaminhado ao laboratório de Patologia Bucal da Faculdade de Odontologia de São José dos Campos - UNESP cujo laudo mostrou lesão cística revestida por epitélio ortoqueratinizado compatível com cisto odontogênico ortoqueratinizado, contradizendo o resultado obtido na biópsia incisional. Atualmente, o paciente encontra-se em proservação há 72 meses, sem indícios de recorrência lesional.
The orthokeratinized odontogenic cyst (OOC) and keratocystic odontogenic tumour (KCOT) are distinct lesions with similar clinical behavior and radiological features. According to the latest edition of the WHO classification, the KCOT is now classified as an odontogenic neoplasm and the OOC continuesto be classified as an odontogenic cyst. This change made in the classification of KCOT was based on scientific evidence that demonstrated that the proliferation rate of these lesions is not compatible with cystic lesions, a fact demonstrated by the high rate of recurrence found in KCOT. Due to their clinical and radiological similarities, the histological differentiation of these lesions is crucial when choosing whether to adopt a conservative or invasive plan of treatment. In this paper, we describe a 28-year-old male patient, caucasian, with asymptomatic increased volume in the mandible in the region of teeth 33, 34 and 35, all with vitality. The imaging studies revealed a radiolucent lesion in the left mandibular body and parasymphysis. The patient underwent aspiration with negative results and incisional biopsy. The material collected was sent to an anatomic pathology laboratory, and the report revealed a keratocystic odontogenic tumour. The patient therefore underwent a surgical enucleation with marginal curettage, with an unremarkable postoperative course. The material collected during the enucleation was sent to the Oral Pathology Department at the School of Dentistry, São José dos Campos - UNESP, whose report revealed a cystic lesion lined by orthokeratinizing epithelium compatible with an orthokeratinized odontogenic cyst, which was at odds with the result obtained in the incisional biopsy. The patient has been followed up for 72 months with no evidence of recurrence of the lesion.
RESUMO
PURPOSE: This study reports a case of a extensive odontoma causing maxillary sinusitis. CASE DESCRIPTION: A 25-year-old man at clinical examination revealed discrete facial asymmetry and exposure of the lesion in the oral cavity. Imaging exams showed the presence of a well-defined radiopaque mass in the left maxilla, measuring approximately 7 cm and was intimately associated with the maxillary sinus and oral cavity. The mass was excised through an intraoral access under general anesthesia in the hospital and sent for histopathology, which was diagnosed as complex odontoma. The patient is under clinical follow-up and shows no signs of maxillary sinusitis and no oral sinus fistula. CONCLUSION: The odontoma is a common injury in clinical dentistry, but in some aggressive cases may cause sequelae in the patient, thus, caution the dentist for proper diagnosis and treatment.
OBJETIVO: Este estudo relata a apresentação de um extenso odontoma causando sinusite maxilar. DESCRIÇÃO DO CASO: Um homem de 25 anos ao exame clínico revelou assimetria facial discreta e exposição da lesão na cavidade oral. Os exames de imagem mostraram a presença de uma massa radiopaca bem definida na maxila esquerda, medindo aproximadamente 7 cm e estava intimamente associado com o seio maxilar e a cavidade oral. A massa foi extirpada através de um acesso intra-oral, sob anestesia geral em ambiente hospitalar e enviada para estudo histopatológico, onde foi diagnosticada como odontoma complexo. O paciente está sob acompanhamento clínico e não mostra sinais de sinusite maxilar e fístula bucossinusal. CONCLUSÃO: O odontoma é uma lesão comum na clínica odontológica, mas pode, em alguns casos, se apresentar de forma agressiva levando a danos ao paciente, e desta forma, é necessária atenção do cirurgião dentista para o correto diagnóstico e tratamento.